GGrantIndex
Sort

85,873 grants matching alzheimers

Models of Estrogen Interactions with Alzheimer Disease

$1,094,182
University Of Southern California · P01 · FY2004 · AG

Gene Regulation In The Immune System

$1,094,006
Keiko Ozato · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2020 · HD

High-performance compact 3T MRI: Technical optimization for advanced brain imaging

$1,093,981
Matthew A. Bernstein · Mayo Clinic Rochester · U01 · FY2018 · EB

Machine learning to distinguish HAND from Alzheimer's disease in HIV over age 60

$1,093,727
Victor Valcour · University Of California, San Francisco · R01 · FY2021 · MH

TDP-43 Proteinopathies in ALS-Dementia

$1,093,540
Virginia M Lee · University Of Pennsylvania · P01 · FY2013 · AG

Phase 1 clinical studies with the gamma-secretase modulator, NGP 555 to establish safety, pharmacokinetics, and biomarker efficacy

$1,093,421
Maria Zoe Kounnas · Neurogenetic Pharmaceuticals, Inc. · R01 · FY2016 · AG

Deciphering innate immune signaling mechanisms in glial cells linking lifetime environmental exposures to neuroinflammation, protein aggregation and neurodegeneration in Parkinsons disease

$1,093,345
Ronald B Tjalkens · Colorado State University · R35 · FY2025 · ES

Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo & HIV ARTs)

$1,092,964
Jeffrey H. Price · Vala Sciences, Inc. · R44 · FY2025 · MH

Functional Validation of TDP-43 splicing repression for frontotemporal degeneration

$1,092,581
Philip C Wong · Johns Hopkins University · UH3 · FY2022 · NS

Aminergic Function Brain Aging and Alzheimer's Disease

$1,092,557
Paula C Bickford · University Of South Florida · P01 · FY2006 · AG

Inclusion of sub-group of ASPREE samples into the ADSP

$1,092,489
Jeffery M. Vance · University Of Miami School Of Medicine · U01 · FY2021 · AG

Family care to nursing home residents and state essential caregiver programs during the COVID-19 pandemic: impact on dementia care, outcomes, and disparities

$1,092,079
Yue Li · University Of Rochester · RF1 · FY2023 · AG

Integrative analysis of multiomic datasets for discovery of molecular underpinnings of large-scale human brain networks

$1,091,985
Mikail Rubinov · Vanderbilt University · RF1 · FY2021 · MH

Clinical

$1,091,780
Randall J Bateman · Washington University · U19 · FY2014 · AG

Alzheimer's Disease Center Core

$1,091,502
University Of Pennsylvania · P30 · FY2003 · AG

The roles of basal forebrain neuronal ensembles in top-down attention

$1,091,498
Shih-Chieh Lin · National Institute On Aging · ZIA · FY2015 · AG

Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines

$1,091,431
Christopher A. Gaiteri · Rush University Medical Center · R01 · FY2021 · AG

Clinical Core

$1,091,351
Suman Jayadev · University Of Washington · P30 · FY2023 · AG

Mild Cognitive Impairment: A Prospective Community Study

$1,091,065
University Of Pittsburgh At Pittsburgh · R01 · FY2005 · AG

Cellular and circuit mechanisms underlying APOE-4 effects on olfaction.

$1,091,036
Shaolin Liu · University Of Georgia · R01 · FY2024 · AG

Alzheimer's Disease Patient Registry (ADPR)

$1,090,693
Eric B Larson · Kaiser Foundation Health Plan Of Washington · U01 · FY2007 · AG

Genetic Epidemiology of Alzheimer's Disease in Hispanics

$1,090,495
Richard Mayeux · Columbia University Health Sciences · R37 · FY2008 · AG

Design And Development Of Experimental Therapeutics

$1,090,483
Nigel H. Greig · National Institute On Aging · ZIA · FY2018 · AG

Peripheral Tissue Biomarker for Premortem Diagnosis of Lewy Body Dementia

$1,090,232
Shu G Chen · Case Western Reserve University · R01 · FY2021 · NS

Peripheral Tissue Biomarker for Premortem Diagnosis of Lewy Body Dementia

$1,090,232
Shu G Chen · University Of Alabama At Birmingham · R01 · FY2023 · NS